Use of prokineticin-1 (PROK1), pregnancy-associated plasma protein A (PAPP-A) and PROK1/PAPP-A ratio to predict adverse pregnancy outcomes in the first trimester: a prospective study.
about
Use of prokineticin-1 (PROK1), pregnancy-associated plasma protein A (PAPP-A) and PROK1/PAPP-A ratio to predict adverse pregnancy outcomes in the first trimester: a prospective study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Use of prokineticin-1 (PROK1), ...... rimester: a prospective study.
@en
Use of prokineticin-1 (PROK1), ...... rimester: a prospective study.
@nl
type
label
Use of prokineticin-1 (PROK1), ...... rimester: a prospective study.
@en
Use of prokineticin-1 (PROK1), ...... rimester: a prospective study.
@nl
prefLabel
Use of prokineticin-1 (PROK1), ...... rimester: a prospective study.
@en
Use of prokineticin-1 (PROK1), ...... rimester: a prospective study.
@nl
P2093
P2860
P1476
Use of prokineticin-1 (PROK1), ...... rimester: a prospective study.
@en
P2093
Cihan Inan
Fusun Gulizar Varol
Havva Sutcu
N Cenk Sayin
Selen Gursoy Erzincan
P2860
P356
10.1080/14767058.2017.1351536
P577
2017-07-04T00:00:00Z